MusclePharm Corporation MSLP OTC

MusclePharm Corporation (MSLP) reported total assets of $11.98M and total liabilities of $50.03M for quarter ending 2022-03-31, resulting in total equity of $-38.06M.

The company held $534K in cash and short-term investments. Total debt stood at $22.64M, with net debt of $22.11M. The Debt-to-Equity (D/E) ratio was -0.59 (conservative).

Current ratio is 0.25, which may signal tight short-term liquidity. Interest coverage is -8.9x (weak).

Criteria supported by this page:

• HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (7/100) — Total assets $11.98M and equity $-38.06M support the company's competitive scale

Overall SharesGrow Score: 11/100 with 0/7 criteria passed.